The prognostic role of red blood cell distribution width in transfused and non-transfused critically ill patients.

BACKGROUND: Red blood cell distribution width (RDW) value is gaining popularity as a prognostic factor in critically ill patients. However, its role in transfused patients is unclear. The aim of this study was to evaluate the predictive value of Red blood cell distribution width (RDW) on Intensive Care Unit (ICU) admission for 90-day mortality among either transfused or non-transfused critically ill patients. METHODS: This observational cohort study includes 286 patients with at least 48 hours of ICU length of stay. Patients were analyzed separately in two groups, depending on whether or not they were transfused in the last 72 hours before ICU admission. RESULTS: One hundred seventeen (117) patients (41%) were transfused. Patients with high RDW on admission (N.=181, 63%) had higher 90-day mortality both in non-transfused (26/87, 30% vs. 12/82, 14% P=0.03) or transfused (39/94, 41% vs. 2/23, 8% P=0.003) patients. The area under the curve of admission RDW values to predict 90-day mortality was 0.660 and 0.610 for non-transfused and transfused patients, respectively. The Youden Index analysis showed that an RDW value of 14.3% was the best cut-off to predict mortality in the non-transfused group, while 15.3% was the best cut-off in the transfused group. CONCLUSIONS: High RDW values on ICU admission are independently associated with 90-day mortality in critically ill patients regardless of previous red blood cells transfusion. However, we identified two different cut-offs of "high RDW" to be used in ICU in transfused and non-transfused patients.

Aeromonas sobria necrotizing fasciitis and sepsis in an immunocompromised patient: a case report and review of the literature.

INTRODUCTION: Aeromonas veronii biovar sobria is a rare cause of bacteremia, with several studies indicating that this isolate may be of particular clinical significance since it is enterotoxin producing. A wide spectrum of infections has been associated with Aeromonas species in developing countries that include gastroenteritis, wound infections, septicemia and lung infections. This infection, caused by Aeromonas species, is usually more severe in immunocompromised than immunocompetent individuals. We here describe a case of soft tissue infection and severe sepsis due to Aeromonas sobria in an immunocompromised patient. CASE PRESENTATION: A 74-year-old Caucasian man with a clinical history of chronic lymphocytic leukemia and immune thrombocytopenia, periodically treated with steroids, was admitted to our Intensive Care Unit because of necrotizing fasciitis and multiorgan failure due to Aeromonas sobria, which resulted in his death. The unfortunate coexistence of a Candida albicans infection played a key role in the clinical course. CONCLUSION: Our experience suggests that early recognition and aggressive medical and surgical therapy are determinants in the treatment of severe septicemia caused by an Aeromonas sobria in an immunocompromised patient.

Time course of expiratory flow limitation in COPD patients during acute respiratory failure requiring mechanical ventilation.

STUDY OBJECTIVES: (1) To determine the incidence of expiratory flow limitation (FL) at ICU admission, at the time of extubation, and at ICU discharge in intubated patients with COPD receiving mechanical ventilation for acute respiratory failure (ARF); and (2) to assess the feasibility of inspiratory capacity (IC) as an indication of pulmonary dynamic hyperinflation in this setting. DESIGN: Prospective, observational pilot study with physiologic measurements performed at ICU admission and during the weaning process driven by the clinician. A 60-min T-tube trial was initiated once criteria for weaning were present. The decision to extubate or reventilate patients was made by the clinician at the end of this session. Assessment of failure or success of T-tube trials was performed independently. SETTING: A 25-bed ICU of a tertiary teaching university hospital. PATIENTS: Over a 13-month period, 25 intubated patients with COPD receiving mechanical ventilation for ARF were included. INTERVENTIONS: None. MEASUREMENTS AND RESULTS: At ICU admission, FL assessed by the negative expiratory pressure test was measured under passive ventilatory conditions at the baseline ventilatory settings, on zero end-expiratory pressure, and in a semirecumbent position. During weaning, FL, respiratory pattern, and IC were measured during T-tube trials, before extubation, 1 h after extubation, and at ICU discharge. At ICU admission, 24 of 25 patients presented FL with, on average, 73 +/- 22% of the tidal volume. Ten patients were unavailable for follow-up due to death (n = 6) unplanned extubation (n = 3), or refusal (n = 1), so that only 15 patients completed the whole protocol (all 15 patients were extubated). For these 15 patients, the incidence of FL was 93% at ICU admission, 47% before extubation, and 40% at ICU discharge. IC was significantly greater at ICU discharge than before extubation (36 +/- 11% predicted vs 44 +/- 12% predicted, p < 0.01) and in successful T-tube trials compared with unsuccessful T-tube trials (38 +/- 13% predicted vs 24 +/- 8% predicted, p < 0.01). CONCLUSIONS: The incidence of expiratory FL is high in patients with COPD receiving mechanical ventilation, and is reduced during aggressive therapy when the patient is placed on mechanical ventilatory support and the time that weaning begins during the ICU stay. IC was lower in patients in whom weaning was unsuccessful. Further large-scale studies are required to confirm these preliminary results.